Table 3:

Changes in Biomarkers over 24 months within each groups

	YLPHIV Median [IQR]	P	HIV- Median [IQR]	P
sCD163 (ng/mL)	−29.00 [−113.50, 44.50]	0.058	−82.00 [−126.00, 5.00]	0.065
sCD14 (ng/mL)	−84.00 [−323.00, 138.00]	0.011	−86.00 [−253.00, 61.00]	0.107
Il6 (pg/mL)	−0.12 [−0.88, 0.58]	0.062	−0.10 [−0.64, 0.78]	0.871
IFAB-P (pg/mL)	−182.00 [−943.50, 447.00]	0.004	−190.00 [−795.75, 245.25]	0.286
sTNF-RII (pg/mL)	−84.00 [−318.00, 198.00]	0.07	−51.00 [−319.50, 253.75]	0.747
oxLDL (mU/L)	344.50 [−4257.25, 4277.25]	0.712	−138.50 [−2424.00, 3786.25]	0.911
hsCRP (mg/L)	−0.12 [−1.60, 1.27]	0.184	0.07 [−0.35, 0.83]	0.098

Median [Interquartile Range]

Bold values represent p<0.05

high sensitivity C reactive protein, IL6: interleukin 6, hsCRP:, IFAB-P: intestinal fatty acid binding protein, oxLDL: oxidized LDL, sCD14 and 163: soluble CD 14 and 163, sTNFR-II: soluble tumor necrosis factor receptor α II